{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:49:46Z","timestamp":1792522186436,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Heterozygous mutations in the Bone morphogenetic protein (BMP) type I receptor <jats:italic>ACVR1<\/jats:italic>, encoding activin-like kinase 2 (ALK2), underlie all cases of the rare genetic musculoskeletal disorder Fibrodysplasia Ossificans Progressiva (FOP). The most commonly found mutant ALK2 p.R206H receptor variant exhibits loss of auto inhibition of BMP signaling and can be activated by Activins, while wild-type receptors remain unresponsive. Consequently, the downstream chondrogenic signaling is enhanced, thus driving heterotopic ossification within soft connective tissues. Despite several investigational treatments being evaluated in clinical trials, no cure for FOP exists today. The cellular and molecular mechanisms underlying disease progression are still being deciphered. In this study, we show a close interplay between the mutant ALK2<jats:sup>R206H<\/jats:sup> receptor signaling and dysregulation of the autophagic flux triggered by hypoxia. Mechanistically, reduced autophagic flux correlates with increased stability of ALK2<jats:sup>R206H<\/jats:sup>, resulting in sustained signaling. Of note, we demonstrated that Rapamycin, under clinical investigation as a treatment for FOP, inhibits chondrogenic differentiation in an autophagy-dependent manner. Consistently, other pharmacological autophagy inducers, like Spermidine, can reduce ALK2<jats:sup>R206H<\/jats:sup> driven chondrogenic differentiation in vitro. These results were verified in FOP patient-derived cells. In conclusion, this study shows that aberrant autophagic flux mediates sustained ALK2<jats:sup>R206H<\/jats:sup> signaling, introducing a novel druggable target in FOP by reactivating autophagy.<\/jats:p>","DOI":"10.1038\/s41420-025-02393-0","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T12:10:47Z","timestamp":1742645447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Interplay between ALK2R206H mutant receptor and autophagy signaling regulates receptor stability and its chondrogenic functions"],"prefix":"10.1038","volume":"11","author":[{"given":"Laura","family":"Coculo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1837-3481","authenticated-orcid":false,"given":"Marius","family":"Wits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Fianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Cappato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Bocciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Pedemonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7985-2422","authenticated-orcid":false,"given":"Elisabetta","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8378-9881","authenticated-orcid":false,"given":"Serena","family":"Ciolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario Luigi","family":"Sessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0682-023X","authenticated-orcid":false,"given":"Serena","family":"Rinaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4621-2135","authenticated-orcid":false,"given":"Francesca","family":"Cutruzzol\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7007-7914","authenticated-orcid":false,"given":"Daniela","family":"Trisciuoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9344-6746","authenticated-orcid":false,"given":"Marie-Jos\u00e8","family":"Goumans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Sanchez-Duffhues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3971-0398","authenticated-orcid":false,"given":"Venturina","family":"Stagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,22]]},"reference":[{"key":"2393_CR1","doi-asserted-by":"crossref","unstructured":"Valer JA, Sanchez-de-Diego C, Pimenta-Lopes C, Rosa JL, Ventura F. ACVR1 function in health and disease. Cells. 2019;8:1366.","DOI":"10.3390\/cells8111366"},{"key":"2393_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115472","volume":"138","author":"G Sanchez-Duffhues","year":"2020","unstructured":"Sanchez-Duffhues G, Williams E, Goumans MJ, Heldin CH, Ten Dijke P. Bone morphogenetic protein receptors: structure, function and targeting by selective small molecule kinase inhibitors. Bone. 2020;138:115472.","journal-title":"Bone"},{"key":"2393_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/jb\/mvp148","volume":"147","author":"K Miyazono","year":"2010","unstructured":"Miyazono K, Kamiya Y, Morikawa M. Bone morphogenetic protein receptors and signal transduction. J Biochem. 2010;147:35\u201351.","journal-title":"J Biochem"},{"key":"2393_CR4","doi-asserted-by":"publisher","unstructured":"Valer JA, Deber A, Wits M, Pimenta-Lopes C, Goumans MJ, Rosa JL, et al. PI3K\u03b1 inhibition blocks osteochondroprogenitor specification and the hyper-inflammatory response to prevent heterotopic ossification. Biorxiv. 2025. https:\/\/doi.org\/10.1101\/2023.09.14.557704.","DOI":"10.1101\/2023.09.14.557704"},{"key":"2393_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.bone.2015.05.025","volume":"80","author":"G S\u00e1nchez-Duffhues","year":"2015","unstructured":"S\u00e1nchez-Duffhues G, Hiepen C, Knaus P, Ten Dijke P. Bone morphogenetic protein signaling in bone homeostasis. Bone. 2015;80:43\u201359.","journal-title":"Bone"},{"key":"2393_CR6","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jpeds.2021.02.036","volume":"232S","author":"P Kannu","year":"2021","unstructured":"Kannu P, Levy CE. Improving the diagnosis of fibrodysplasia ossificans progressiva. J Pediatr. 2021;232S:S3\u2013S8.","journal-title":"J Pediatr"},{"key":"2393_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-6-80","volume":"6","author":"RJ Pignolo","year":"2011","unstructured":"Pignolo RJ, Shore EM, Kaplan FS. Fibrodysplasia ossificans progressiva: clinical and genetic aspects. Orphanet J Rare Dis. 2011;6:80.","journal-title":"Orphanet J Rare Dis"},{"key":"2393_CR8","doi-asserted-by":"crossref","unstructured":"Ventura F, Williams E, Ikeya M, Bullock AN, Ten Dijke P, Goumans MJ, et al. Challenges and opportunities for drug repositioning in fibrodysplasia ossificans progressiva. biomedicines. 2021;9:213.","DOI":"10.3390\/biomedicines9020213"},{"key":"2393_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/ng1783","volume":"38","author":"EM Shore","year":"2006","unstructured":"Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ, Choi IH, et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet. 2006;38:525\u20137.","journal-title":"Nat Genet"},{"key":"2393_CR10","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1002\/jbmr.1637","volume":"27","author":"SA Chakkalakal","year":"2012","unstructured":"Chakkalakal SA, Zhang D, Culbert AL, Convente MR, Caron RJ, Wright AC, et al. An Acvr1 R206H knock-in mouse has fibrodysplasia ossificans progressiva. J Bone Min Res. 2012;27:1746\u201356.","journal-title":"J Bone Min Res"},{"key":"2393_CR11","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.bone.2017.10.027","volume":"109","author":"J Haupt","year":"2018","unstructured":"Haupt J, Xu M, Shore EM. Variable signaling activity by FOP ACVR1 mutations. Bone. 2018;109:232\u201340.","journal-title":"Bone"},{"key":"2393_CR12","doi-asserted-by":"publisher","first-page":"303ra137","DOI":"10.1126\/scitranslmed.aac4358","volume":"7","author":"SJ Hatsell","year":"2015","unstructured":"Hatsell SJ, Idone V, Wolken DM, Huang L, Kim HJ, Wang L, et al. ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A. Sci Transl Med. 2015;7:303ra137.","journal-title":"Sci Transl Med"},{"key":"2393_CR13","doi-asserted-by":"publisher","first-page":"15438","DOI":"10.1073\/pnas.1510540112","volume":"112","author":"K Hino","year":"2015","unstructured":"Hino K, Ikeya M, Horigome K, Matsumoto Y, Ebise H, Nishio M, et al. Neofunction of ACVR1 in fibrodysplasia ossificans progressiva. Proc Natl Acad Sci USA. 2015;112:15438\u201343.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2393_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1196\/annals.1315.023","volume":"1038","author":"W Vale","year":"2004","unstructured":"Vale W, Wiater E, Gray P, Harrison C, Bilezikjian L, Choe S. Activins and inhibins and their signaling. Ann N Y Acad Sci. 2004;1038:142\u20137.","journal-title":"Ann N Y Acad Sci"},{"key":"2393_CR15","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1002\/jbmr.2848","volume":"31","author":"H Wang","year":"2016","unstructured":"Wang H, Lindborg C, Lounev V, Kim JH, McCarrick-Walmsley R, Xu M, et al. Cellular hypoxia promotes heterotopic ossification by amplifying BMP signaling. J Bone Min Res. 2016;31:1652\u201365.","journal-title":"J Bone Min Res"},{"key":"2393_CR16","doi-asserted-by":"crossref","unstructured":"Wang H, Kaplan FS, Pignolo RJ. The HIF-1\u03b1 and mTOR pathways amplify heterotopic ossification. Biomolecules. 2024;14:147.","DOI":"10.3390\/biom14020147"},{"key":"2393_CR17","doi-asserted-by":"crossref","unstructured":"Diolintzi A, Pervin MS, Hsiao EC. Immunologic aspects in fibrodysplasia ossificans progressiva. Biomolecules. 2024;14:357.","DOI":"10.3390\/biom14030357"},{"key":"2393_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cell.2018.09.048","volume":"176","author":"B Levine","year":"2019","unstructured":"Levine B, Kroemer G. Biological functions of autophagy genes: a disease perspective. Cell. 2019;176:11\u201342.","journal-title":"Cell"},{"key":"2393_CR19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41580-018-0003-4","volume":"19","author":"I Dikic","year":"2018","unstructured":"Dikic I, Elazar Z. Mechanism and medical implications of mammalian autophagy. Nat Rev Mol Cell Biol. 2018;19:349\u201364.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2393_CR20","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101167R","volume":"35","author":"JJ Moss","year":"2021","unstructured":"Moss JJ, Wirth M, Tooze SA, Lane JD, Hammond CL. Autophagy coordinates chondrocyte development and early joint formation in zebrafish. FASEB J. 2021;35:e22002.","journal-title":"FASEB J"},{"key":"2393_CR21","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13:132\u201341.","journal-title":"Nat Cell Biol"},{"key":"2393_CR22","doi-asserted-by":"publisher","first-page":"1030S","DOI":"10.1177\/19476035211035434","volume":"13","author":"J Lu","year":"2021","unstructured":"Lu J, Peng Y, Zou J, Wang J, Lu S, Fu T, et al. Hypoxia inducible factor-1\u03b1 is a regulator of autophagy in osteoarthritic chondrocytes. Cartilage. 2021;13:1030S\u201340S.","journal-title":"Cartilage"},{"key":"2393_CR23","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.stemcr.2018.10.007","volume":"11","author":"K Hino","year":"2018","unstructured":"Hino K, Zhao C, Horigome K, Nishio M, Okanishi Y, Nagata S, et al. An mTOR signaling modulator suppressed heterotopic ossification of fibrodysplasia ossificans progressiva. Stem Cell Rep. 2018;11:1106\u201319.","journal-title":"Stem Cell Rep"},{"key":"2393_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.slasd.2024.100196","volume":"29","author":"M Wits","year":"2024","unstructured":"Wits M, Haarmans N, Sanchez-Duffhues G, Goumans MJ. TGF-beta receptor-specific NanoBRET target engagement in living cells for high-throughput kinase inhibitor screens. SLAS Discov. 2024;29:100196.","journal-title":"SLAS Discov"},{"key":"2393_CR25","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.molcel.2016.09.037","volume":"64","author":"T Kaizuka","year":"2016","unstructured":"Kaizuka T, Morishita H, Hama Y, Tsukamoto S, Matsui T, Toyota Y, et al. An autophagic flux probe that releases an internal control. Mol Cell. 2016;64:835\u201349.","journal-title":"Mol Cell"},{"key":"2393_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2020.1797280","volume":"17","author":"DJ Klionsky","year":"2021","unstructured":"Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 2021;17:1\u2013382.","journal-title":"Autophagy"},{"key":"2393_CR27","first-page":"3","volume":"66","author":"A Biederbick","year":"1995","unstructured":"Biederbick A, Kern HF, Els\u00e4sser HP. Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. Eur J Cell Biol. 1995;66:3\u201314.","journal-title":"Eur J Cell Biol"},{"key":"2393_CR28","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.chembiol.2018.04.010","volume":"25","author":"E Sondo","year":"2018","unstructured":"Sondo E, Falchi F, Caci E, Ferrera L, Giacomini E, Pesce E, et al. Pharmacological inhibition of the ubiquitin ligase RNF5 rescues F508del-CFTR in cystic fibrosis airway epithelia. Cell Chem Biol. 2018;25:891\u2013905.e8.","journal-title":"Cell Chem Biol"},{"key":"2393_CR29","doi-asserted-by":"crossref","unstructured":"Sun L, Jin Y, Nishio M, Watanabe M, Kamakura T, Nagata S, et al. Oxidative phosphorylation is a pivotal therapeutic target of fibrodysplasia ossificans progressiva. Life Sci Alliance. 2024;7:e202302219.","DOI":"10.26508\/lsa.202302219"},{"key":"2393_CR30","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","volume":"8","author":"V Panwar","year":"2023","unstructured":"Panwar V, Singh A, Bhatt M, Tonk RK, Azizov S, Raza AS, et al. Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease. Signal Transduct Target Ther. 2023;8:375.","journal-title":"Signal Transduct Target Ther"},{"key":"2393_CR31","volume":"3","author":"G S\u00e1nchez-Duffhues","year":"2019","unstructured":"S\u00e1nchez-Duffhues G, Williams E, Benderitter P, Orlova V, van Wijhe M, Garcia de Vinuesa A, et al. Development of macrocycle kinase inhibitors for ALK2 using fibrodysplasia ossificans progressiva-derived endothelial cells. JBMR. 2019;3:e10230.","journal-title":"JBMR"},{"key":"2393_CR32","doi-asserted-by":"crossref","unstructured":"Madeo F, Eisenberg T, Pietrocola F, Kroemer G. Spermidine in health and disease. Science. 2018;359:eaan2788.","DOI":"10.1126\/science.aan2788"},{"key":"2393_CR33","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/ncb1854","volume":"11","author":"Y Zhong","year":"2009","unstructured":"Zhong Y, Wang QJ, Li X, Yan Y, Backer JM, Chait BT, et al. Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1-phosphatidylinositol-3-kinase complex. Nat Cell Biol. 2009;11:468\u201376.","journal-title":"Nat Cell Biol"},{"key":"2393_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2022.119284","volume":"1869","author":"CB Trelford","year":"2022","unstructured":"Trelford CB, Di Guglielmo GM. Autophagy regulates transforming growth factor \u03b2 signaling and receptor trafficking. Biochim Biophys Acta Mol Cell Res. 2022;1869:119284.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"2393_CR35","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/path.5322","volume":"249","author":"MC Gomez-Puerto","year":"2019","unstructured":"Gomez-Puerto MC, van Zuijen I, Huang CJ, Szulcek R, Pan X, van Dinther MA, et al. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension. J Pathol. 2019;249:356\u201367.","journal-title":"J Pathol"},{"key":"2393_CR36","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/j.celrep.2018.10.056","volume":"25","author":"DSJ Miller","year":"2018","unstructured":"Miller DSJ, Bloxham RD, Jiang M, Gori I, Saunders RE, Das D, et al. The dynamics of TGF-\u03b2 signaling are dictated by receptor trafficking via the ESCRT machinery. Cell Rep. 2018;25:1841\u201355.e5.","journal-title":"Cell Rep"},{"key":"2393_CR37","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1016\/j.celrep.2019.11.063","volume":"29","author":"ES Bell","year":"2019","unstructured":"Bell ES, Coelho PP, Ratcliffe CDH, Rajadurai CV, Peschard P, Vaillancourt R, et al. LC3C-mediated autophagy selectively regulates the met RTK and HGF-stimulated migration and invasion. Cell Rep. 2019;29:4053\u201368.e6.","journal-title":"Cell Rep."},{"key":"2393_CR38","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1172\/JCI93521","volume":"127","author":"K Hino","year":"2017","unstructured":"Hino K, Horigome K, Nishio M, Komura S, Nagata S, Zhao C, et al. Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva. J Clin Investig. 2017;127:3339\u201352.","journal-title":"J Clin Investig"},{"key":"2393_CR39","doi-asserted-by":"crossref","unstructured":"Yang J, Kitami M, Pan H, Nakamura MT, Zhang H, Liu F, et al. Augmented BMP signaling commits cranial neural crest cells to a chondrogenic fate by suppressing autophagic \u03b2-catenin degradation. Sci Signal. 2021;14:eaaz9368.","DOI":"10.1126\/scisignal.aaz9368"},{"key":"2393_CR40","doi-asserted-by":"publisher","first-page":"8048","DOI":"10.18632\/aging.102355","volume":"11","author":"MV Blagosklonny","year":"2019","unstructured":"Blagosklonny MV. Rapamycin for longevity: opinion article. Aging. 2019;11:8048\u201367.","journal-title":"Aging"},{"key":"2393_CR41","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/15548627.2018.1530929","volume":"15","author":"F Madeo","year":"2019","unstructured":"Madeo F, Bauer MA, Carmona-Gutierrez D, Kroemer G. Spermidine: a physiological autophagy inducer acting as an anti-aging vitamin in humans? Autophagy. 2019;15:165\u20138.","journal-title":"Autophagy"},{"key":"2393_CR42","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/s43587-022-00322-9","volume":"2","author":"SJ Hofer","year":"2022","unstructured":"Hofer SJ, Simon AK, Bergmann M, Eisenberg T, Kroemer G, Madeo F. Mechanisms of spermidine-induced autophagy and geroprotection. Nat Aging. 2022;2:1112\u201329.","journal-title":"Nat Aging"},{"key":"2393_CR43","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1093\/gerona\/glab145","volume":"76","author":"CY Liao","year":"2021","unstructured":"Liao CY, Kummert OMP, Bair AM, Alavi N, Alavi J, Miller DM, et al. The autophagy inducer spermidine protects against metabolic dysfunction during overnutrition. J Gerontol A Biol Sci Med Sci. 2021;76:1714\u201325.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2393_CR44","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1111\/bph.14706","volume":"176","author":"J Yan","year":"2019","unstructured":"Yan J, Yan JY, Wang YX, Ling YN, Song XD, Wang SY, et al. Spermidine-enhanced autophagic flux improves cardiac dysfunction following myocardial infarction by targeting the AMPK\/mTOR signalling pathway. Br J Pharmacol. 2019;176:3126\u201342.","journal-title":"Br J Pharmacol"},{"key":"2393_CR45","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1080\/15548627.2023.2170962","volume":"19","author":"FR Pellegrini","year":"2023","unstructured":"Pellegrini FR, De Martino S, Fianco G, Ventura I, Valente D, Fiore M, et al. Blockage of autophagosome-lysosome fusion through SNAP29 O-GlcNAcylation promotes apoptosis via ROS production. Autophagy. 2023;19:2078\u201393.","journal-title":"Autophagy"},{"key":"2393_CR46","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.3389\/fphar.2018.01464","volume":"9","author":"E Pesce","year":"2018","unstructured":"Pesce E, Sondo E, Ferrera L, Tomati V, Caci E, Scudieri P, et al. The autophagy inhibitor spautin-1 antagonizes rescue of mutant CFTR through an autophagy-independent and USP13-mediated mechanism. Front Pharmacol. 2018;9:1464.","journal-title":"Front Pharmacol"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02393-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02393-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02393-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T23:50:05Z","timestamp":1742687405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02393-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,22]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2393"],"URL":"https:\/\/doi.org\/10.1038\/s41420-025-02393-0","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,22]]},"assertion":[{"value":"8 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. Control and FOP ECFCs were isolated from peripheral blood in citrate-treated collection tubes after obtaining written informal consent in accordance with the institutional guidelines of Leiden University Medical Center (LUMC, Leiden, Netherlands). These cell lines were previously introduced and characterized in G. Sanchez-Duffhues et al., JBMRPlus,2019 [].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"117"}}